Children's Orthopaedics of Atlanta, Atlanta, Georgia
Orthopaedic Surgery, The Southeast Permanente Medical Group, Jonesboro, Georgia
J Bone Joint Surg Am. 2016 Jun 15;98(12):1030-40. doi: 10.2106/JBJS.15.01002.
The purposes of this study were to validate an innovative, percutaneous method of monitoring femoral head (epiphyseal) perfusion intraoperatively in patients with slipped capital femoral epiphysis (SCFE) and to investigate an association between intraoperative perfusion and the subsequent development of osteonecrosis.
A percutaneous screw fixation technique for SCFE was utilized. A fully threaded, cannulated, stainless-steel 7.0-mm screw was inserted into the epiphysis. The guidewire was removed, and a sterile intracranial pressure (ICP) probe was placed through the screw such that the tip was in the epiphyseal bone past the end of the screw. Intraoperative epiphyseal pressure and waveform were recorded. A prospective analysis of patients undergoing percutaneous screw fixation for unstable or stable SCFE or for prophylactic treatment with the use of this technique to evaluate femoral head perfusion was performed.
This technique was used in 23 patients (29 hips, including 15 hips with unstable SCFE, 11 with stable SCFE, and 3 treated prophylactically). Three hips (2 with unstable SCFE and 1 treated prophylactically) in 2 patients were eliminated from the analysis because of technical problems with the ICP monitor. All hips with stable SCFE and the prophylactically treated hips had measurable pulsatile flow that was synchronous with the patient's heart rate at the initial time of probe insertion. Seven patients (7 hips) with unstable SCFE had measurable, pulsatile flow with initial insertion of the probe, and 6 patients (6 hips) with unstable SCFE had no measurable flow. We were able to demonstrate perfusion following a percutaneous capsular decompression in the patients with no initial flow. All patients left the operating room with measurable femoral head blood flow. At a mean follow-up of 1.6 years for hips with stable SCFE and 2.0 years for those with unstable SCFE, no hip subsequently developed radiographic evidence of osteonecrosis of the femoral head. No complications from the use of the ICP monitor occurred.
Femoral head perfusion in patients with SCFE can be measured intraoperatively using this technique. Demonstrating femoral head perfusion before leaving the operating room was associated with the absence of osteonecrosis postoperatively.
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
本研究的目的是验证一种创新的经皮监测术,以监测髋关节滑囊炎(SCFE)患者术中股骨头(骨骺)的灌注,并探讨术中灌注与随后发生骨坏死之间的关系。
采用经皮 SCFE 螺钉固定技术。将一根全螺纹、套管、不锈钢 7.0 毫米螺钉插入骨骺。取出导丝,将无菌颅内压(ICP)探头穿过螺钉放置,探头尖端进入骨骺骨,超过螺钉末端。术中记录骨骺压力和波形。对 23 例(29 髋)接受经皮螺钉固定治疗不稳定或稳定 SCFE 或预防性使用该技术治疗的患者进行前瞻性分析,以评估股骨头灌注。
2 例患者中有 3 髋(2 例不稳定 SCFE 和 1 例预防性治疗)因 ICP 监测器技术问题而被排除在分析之外。所有稳定 SCFE 患者和预防性治疗患者的髋部在探头初始插入时均有可测量的搏动性血流,与患者心率同步。7 例(7 髋)不稳定 SCFE 患者在初始插入探头时有可测量的搏动性血流,6 例(6 髋)不稳定 SCFE 患者无可测量的血流。我们能够在初始无血流的患者中证明经皮囊减压后的灌注。所有患者在离开手术室时均有可测量的股骨头血流。在稳定 SCFE 患者的平均随访 1.6 年和不稳定 SCFE 患者的平均随访 2.0 年后,没有髋部随后出现股骨头坏死的影像学证据。使用 ICP 监测器未发生任何并发症。
使用该技术可以在术中测量 SCFE 患者的股骨头灌注。在离开手术室前证明股骨头灌注与术后无骨坏死有关。
治疗 IV 级。有关证据水平的完整描述,请参阅作者指南。